Keyphrases
Molecular Targets
100%
Glioblastoma multiforme
100%
Delivery System
100%
Mechanism-based Therapy
100%
Glioma
50%
Epidermal Growth Factor Receptor
50%
Genetic Modification
25%
Angiogenesis
25%
Molecular Mechanism
25%
Clinical Setting
25%
Novel Therapeutics
25%
Therapeutic Approaches
25%
Tumor
25%
Novel Diagnostics
25%
Blood Vessels
25%
Chronic Disease
25%
Primary Brain Tumor
25%
Gene Expression Profile
25%
P53 Pathway
25%
Diagnostic Approach
25%
Genetic Status
25%
Adenosine
25%
Tyrosine Kinase Inhibitor
25%
Farnesyltransferase Inhibitor
25%
Salvage Pathway
25%
Tumor Genomics
25%
PTEN mutation
25%
Endothelin Receptor
25%
Atrasentan
25%
Proteomic Profile
25%
Tumor Genetics
25%
Retinoblastoma Pathway
25%
ZD1839
25%
1p/19q Loss
25%
Tumor Proteomics
25%
Methylthioadenosine Phosphorylase
25%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Proteomics
100%
Tyrosine Kinase Inhibitor
50%
Farnesyltransferase
50%
Genetics
50%
Gene Expression
50%
Gene Mutation
50%
Angiogenesis
50%
Retinoblastoma
50%
Endothelin Receptor
50%
Phosphorylase
50%
Genomics
50%
Adenosine
50%
Pharmacology, Toxicology and Pharmaceutical Science
Molecular Target
100%
Glioblastoma
100%
Neoplasm
75%
Epidermal Growth Factor Receptor
50%
Protein Tyrosine Kinase Inhibitor
25%
Brain Cancer
25%
Chronic Disease
25%
Gefitinib
25%
Tipifarnib
25%
Protein Farnesyltransferase Inhibitor
25%
Endothelin Receptor
25%
Atrasentan
25%
5' Methylthioadenosine Phosphorylase
25%
Retinoblastoma
25%
Adenosine
25%
Neuroscience
Glioblastoma Multiforme
100%
Proteomics
50%
Epidermal Growth Factor Receptor
50%
Retinoblastoma
25%
TP53
25%
Gene Mutation
25%
Gene Expression
25%
Adenosine
25%
Tyrosine Kinase Inhibitor
25%
5' Methylthioadenosine Phosphorylase
25%
Angiogenesis
25%
Farnesyltransferase Inhibitor
25%
Endothelin Receptor
25%
Tipifarnib
25%
Intracranial Tumor
25%